123 Main Street, New York, NY 10001

Top Navigation with Mega Menu
Investor Relations
Changing the Future

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to locate genetic markers for use in applications other than infectious disease.

Learn More

Latest News
Jul 16, 2026

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced...

Jul 8, 2026

Invited by the Stop TB Partnership and the Global Fund to participate as a manufacturer partner Workshop brings together national TB programs, researchers, donors, and technical agencies from 21...

Jul 1, 2026

More than 1,400 patients enrolled across 9 clinical sites; analytical performance testing included 27 individual studies and over 10,000 PCR test cup runs Analytical data to support concurrent...

All Releases

Stock Information
NASDAQCODX
Events
Thursday, May 14, 2026
4:30pm - 5:30pm EDT
Tuesday, March 31, 2026
4:30pm - 5:30pm EDT

All Events

Join Our Newsletter

Receive our latest blog posts directly in your inbox!